Shaista Asif is the Group Chief Operating Officer at Pure Health, the largest integrated healthcare company in the UAE. Overseeing the Group’s diversified portfolio, including hospitals, clinics, laboratories, health insurance, healthcare procurement, and health tech solutions, Shaista is at the forefront in changing the way healthcare is delivered in the country. She has spearheaded the largest number of healthcare acquisitions in the UAE over the last three years, making Pure Health the fastest-growing healthcare company in the region. With a strong track record in delivering transformational change, Shaista has led Pure Health’s consolidation, spearheading the execution of the Group’s strategy, quality distinction, growth, and development in the healthcare segment in the UAE since 2010. With over 17 years in senior leadership positions in the healthcare and technology domain, Shaista brings a wealth of experience in strategic planning and is recognised for her in-depth analytical ability to facilitate operational and procedural planning to focus on the Group’s growth and optimisation. Moving from sick care to preventive care, Shaista’s North Star is Longevity. Pure Health is working towards creating the ‘Healthcare in the Cloud’ as its enabler, where the company is focused on embracing the 4th Industrial Revolution. Shaista believes in Technological Singularity, and how the increase in compute power is bringing it closer. Pure Health is working towards creating a healthcare ecosystem where people don’t fall sick, but instead live healthier and fuller lives, for longer!

Dr. Fatima Al Kaabi is the Executive Director of Abu Dhabi Bone Marrow Transplant Program (AD-BMT^©) at Abu Dhabi Stem Cells Center (ADSCC), and Vice-Chair of UAE National MS Society Board of Trustees. She obtained her MPH in 2001 from Bloomberg School of Public Health, John Hopkins University; MSc in Cancer in 2012 from the University College of London; and did her fellowship in hematology in the Royal Free Hospital, in the United Kingdom. Dr. Al Kaabi has held multiple senior positions in the past including the Head of Adult Hematology/Oncology and Deputy Chief Medical Officer at Sheikh Khalifa Medical City (SKMC).

A leading healthcare influencer, Her Excellency Dr Maryam Matar pioneered the study of genes and advocates public education and awareness of genetic disorders across the ME region. A true game changer in the field of genetic research and biotechnology in the Arab world, she is single-handedly responsible for putting the UAE on the global map of genetic research and innovation. As the pioneer genetic scientist, she played a lead role in bringing new legislation for pre-marital screening, preventive genetic testing, and relevant mandatory legislation at the government level in the UAE. Dr. Matar holds key roles as Co-chair and committee member of the Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease, a member of the Panel of Experts in the WHO Collective Global Network for Rare Diseases (WHO CGN4RD), and as Steering Committee Co-Lead for the NNEdPro Middle East Regional Network. She also serves as one of two chosen Arab Women members on the Selection Committee of the Zayed Sustainability Award, carries the title of Ambassador of Science for Regional magazine & Women in STEM by Springer Nature, and contributes as an Advisory Committee Member to various universities in the UAE and other organizations. As a medical doctor, Dr. Matar's significant contributions have earned her recognition as one of the top 20 Arab researchers with the most profound impact on humanity, and she has achieved several historic milestones, including being the first Emirati woman to hold the position of Senior Undersecretary of the Ministry of Health in 2006.

Maqsoud Kruse grew up in a multicultural and multiethnic family environment to a German father and an Emirati mother, which enabled him to have a deep understanding of cultural and social influences on oneself and on others as well as appreciating the values of tolerance, coexistence, and diversity. Discovering his passion for Psychology at the early age of thirteen, he has been ever since interested in mental health and wellness, the cultivation of human potential, and the identification of giftedness and special abilities. This is reflected in his broad and interdisciplinary intellectual and scientific interests that include but are not limited to Clinical Psychology, Organizational Psychology, Psychological and Neurological Sciences, Gifted Education, Strategic Studies, Political Propaganda, Tolerance, Extremism and Terrorism, Political Islam, and Contemporary Arabic Thought. In 2021, Kruse published a study titled "Year of the Fiftieth: The Role of Industrial & Organizational Psychology in Cultivating Human Potential in the United Arab Emirates" that was published by Trends Research & Advisory. In the same year, he published a study titled "The Challenges of Developing Inclusive Curriculum for Gifted Students in The United Arab Emirates" that was also published by Trends Research & Advisory. In 2019, Kruse published a book chapter in Arabic titled “The Psychological Foundations of Tolerance” that was published by the Sultan Bin Zayed Center. In the same year, he published his paper titled “Towards A Neurological Model of Giftedness: A Conceptual Perspective” at the 4th International Conference on Educational Neuroscience. His paper titled “Countering Violent Extremism Strategies in the Muslim World” appeared in “The ANNALS” of The American Academy of Political and Social Science in 2016. Kruse has been serving as the Chairperson of the National Human Rights Institution in the United Arab Emirates since its inception in 2021, in which he’s been dedicating part of his work to the advocacy and promotion of the “Right to Mental Health”.

Ayman Mokhtar is Viatris Regional President for the Middle East, Turkey & Levant Region. Viatris is the global healthcare company formed in November 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. Viatris empowers people to live healthier at every stage of life. Viatris portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases. With more than twenty years of experience in the pharmaceutical industry, Ayman is an executive with a broad international experience having held strategic positions within multinational companies and lead regional operations covering the Middle East and Africa. His most recent roles have been Regional Strategy Lead for Africa and the Middle East at Pfizer and General Manager GCC Countries for Upjohn a division of Pfizer. Ayman has a passion for improving patient access to medications through innovative approaches, connecting stakeholders on common goals and driving meaningful partnerships. In his active external engagement as board member of several trade associations in the Middle East Region, he strongly advocates for the importance of collective efforts to optimize healthcare services and healthcare delivery in the Region. Ayman has been able to forge several public private partnerships in research, awareness, patient access across the region, notably in the UAE.

Dr. Fouziyah, a visionary leader in the healthcare industry, serves as the esteemed CEO of Al Inma Medical Services and is the dedicated Owner & Operator of the renowned Hayat National Hospitals Group. With a profound commitment to improving healthcare accessibility and quality, Dr. Fouziyah has steered Al Inma Medical Services to new heights of excellence. Her strategic acumen, coupled with a compassionate approach to patient care, has transformed the organization into a beacon of medical innovation and patient-centered services. As the driving force behind Hayat National Hospitals Group, Dr. Fouziyah has fostered a culture of excellence in medical care. Under her guidance, the group has expanded its footprint, providing cutting-edge treatments and compassionate care to communities far and wide. Dr. Fouziyah's unwavering dedication to advancing healthcare, coupled with her leadership prowess, has earned her recognition as a prominent figure in the medical field. Her enduring commitment to enhancing the well-being of individuals and communities underscores her legacy in the healthcare sector.

Russell Hemmings, a Dubai-based life coach, author, and hypnotherapist, enjoys worldwide acclaim and extensive coverage in the global media. He is especially known for his distinctive methods in addressing panic attacks, anxiety, and his impactful work with children and teenagers. With over three decades of experience, Russell has consistently delivered dedicated assistance, guidance, and support to clients in both Dubai and the United Kingdom.

Mohamed Mostafa is the Chief Executive Officer of PDC-CRO and serves on its Board of Directors. Mohamed leads a workforce in supporting Pharmaceuticals, Biotech companies and Research Institutions on the clinical development and transformational research. Mohamed’s inspiration and passion for clinical research led him to focus on how clinical research can improve patient’s lives. Over two decades of versed experience, he dedicated his efforts to expand research capabilities and infrastructure to provide patients an option to access new treatments. PDC is a leading CRO in the Middle East and Africa Region that focuses on early-stage clinical development, operational management of clinical trials and regulatory services. More recently, the company’s rapid response to the COVID-19 pandemic drove a coordination of global and regional initiatives to safeguard the health of people and ensure vaccines, life-saving medicines and products reach patients and communities in need. Mohamed holds a bachelor’s degree in Pharmaceutical Science from Egypt and is currently responsible for the overall management and strategic initiatives within the organization. Prior to that, he was heading the Clinical Operations across different CROs and Pharmaceutical Companies like Novartis and Roche. In his capacity, he was responsible for various scientific initiatives with local and international partners and worked closely with regulatory agencies across the region on various guidelines and strategic plans.

HH Sayyida Basma's career spans over 24 years, during which she founded Oman's first mental health clinic Whispers of Serenity. Her visionary leadership extends to the groundbreaking "Not Alone" campaign, aimed at promoting mental health awareness. Notably, she is among the few psychotherapists in the Gulf region employing innovative techniques such as Hypnotherapy and Prolonged Exposure Therapy (PET) for PTSD, honed during her training at Harvard University. In 2008, she earned her Master's Degree in Health Counseling from Curtin University of Technology in Australia, providing her with a solid foundation for her illustrious career. HH Sayyida Basma's commitment to mental well-being goes beyond clinical practice. In response to the COVID-19 pandemic, the Not Alone campaign established a messaging support line, offering psychological and emotional support to diverse groups, including teens, the elderly, and frontline health workers. During times of crisis, such as in Beirut, Palestine, Turkey, Syria, and now to Morocco and Libya, she and her team of psychologists offered free counseling services. Furthermore, Sayyida Basma serves as the Honorary President of Oman Heritage, preserving and celebrating Omani traditions and culture. With over 800 talks, workshops, and webinars delivered in both governmental and private institutions globally, her expertise is sought after by diverse audiences.

Schroeckenfuchs has been working with Novartis for almost 22 years. In his current role, he oversees a team of over 450 people. In March 2022, it partnered with Pharmax Pharmaceuticals to enhance access to treatment for cardiovascular disease and Type 2 diabetes in the U.A.E. In June 2023, Novartis also partnered with the Emirates Dermatology Society to raise awareness of skin diseases.

Farah N. Hamdan is a seasoned business leader with more than 18 years of experience in the Healthcare industry with a profound knowledge in the Pharmaceutical and Medical device sectors. She has extensive experience in Leadership, Transformation and strategy roles within global organizations in different geographies. In her current role as General Manager spanning Middle East , North Africa and Turkey For Zimmer Biomet ; Farah is responsible for the regional growth through enhancing the footprint and investment across the area during this transformative period in Health care. Her Main Focus is partnering with hospitals and health authorities to help them benefit from Zimmer Biomet’s technology and data to improve efficiency and patient outcomes to alleviate pain and improve quality of life for people around the world. Prior to joining Zimmer Biomet, Farah held various senior roles in Becton Dickinson, Medtronic, Abbott, and Novartis Pharma across the Emerging Markets. Her multiple Awards reflect accomplishments in growth , innovation , and building high performance cultures . Farah holds a Bachelor of Science in Pharmacy from Jordan University of Science & Technology, a Masters degree in International Business from the University of Wollongong (Australia), and a Post Graduate Diploma in Leadership from University of Glasgow Caledonian University (UK).

Hayat Biotech's Senior Advisor and Head of Research and Development, Dr. Nawal Al Kaabi is a highly accomplished infectious diseases consultant and an esteemed figure in the field. She has been the Chair of the SEHA Infectious Diseases and Infection Control Council since 2012 and previously served as Chief Medical Officer at Sheikh Khalifa Medical City. In recognition of her invaluable contributions to public health, she was appointed as the Chair of the National Covid-19 Clinical Committee in February 2020. Dr. Al Kaabi is also a renowned pediatric consultant who has made significant contributions to her field. An accomplished researcher, Dr. Al Kaabi has published numerous papers and has presented her findings at several international conferences, as well as serves as the Principal Investigator of multiple clinical trials. Furthermore, Dr. Nawal is a member of the WHO Guideline Development Group for Monkeypox and was part of the experts that developed WHO guiding principles for pathogen genome data sharing. An accomplished researcher, Dr. Al Kaabi has published numerous papers and has presented her findings at several international conferences. She serves as the Principal Investigator of multiple clinical trials, including the randomized, double-blind, parallel placebo-controlled, phase III clinical trial to evaluate the safety and efficacy of inactivated SARS-CoV-2 vaccines in the healthy population aged 18 years old and above.

Scheuer joined Sanofi in 2008 and assumed his current role in 2016, in which he leads a team of 800 people. He was previously country chair and general manager at Sanofi Gulf from 2016 to 2020. Between 2020 and 2022, the company launched over 40 products, with over 13 launches in 2022 alone.

Chongphaisal has been working at GSK for almost 13 years, and he has more than 20 years of experience. He assumed his role in August 2023 to oversee more than 250 people in the Gulf. In 2022, GSK signed a manufacturing agreement with Bioventure Healthcare and Globalpharma through which GSK will transfer the secondary packaging of some of its key products to the U.A.E.

Ehab Zawaideh is an accomplished leader with more than 28 years of experience managing businesses in the healthcare industry in the Middle East. Currently working with GE Healthcare as the Middle East General Manager, responsible for managing the business activities and developing and implementing effective business strategies that include identifying business opportunities, maintaining relationships with customers and healthcare providers, ensuring sustainability, coaching, and building highly efficient teams, and meeting business objectives. Ehab is a committed, results-driven leader with specialized experience in the healthcare sector. In his more than 18 years with GE Healthcare, he has held senior roles in nearly every modality in the company portfolio including molecular imaging & computed tomography, interventional radiology & cardiology, diagnostic X-Ray, imaging, surgery and navigation, and has managed multicultural teams across Africa, the Middle East, Central Asia, and Turkey. Prior to GE, Ehab worked with BrainLAB, the leading German medical technology company for Image Guided Surgery and Oncology Solutions that he proudly introduced and established in the Middle East, something that had a great impact on the field of neurosurgery and enabled surgeons to conduct more precise and safer operations. This introduction positioned UAE as a leader in advanced neurosurgical procedures in the region.

Hugo Hagen is the Senior Bayer Representative and Country Division Head Pharmaceutical – Bayer Middle East. In this role, he is responsible for 16 countries with regional offices throughout the Middle East. Hugo is dedicated to creating a high performing corporate culture that promote business excellence, innovation, with strong focus on sustainability and continuous talent development. With more than 25 years of experience in business, holding various positions in marketing and sales, with and without managerial responsibilities, Hugo is a is a passionate and strong leader. Throughout his international career he has been responsible for driving teams and organizations in fostering a winning culture with excellent accomplishments. Before he moved to Dubai, he worked in various managerial position in and outside of Europe. Hugo studied marketing and basic pharmacology in Oslo Norway.

Dr. Naser Ammash is a Professor of Medicine, Mayo Clinic College of Medicine, and a Consultant in Cardiovascular (CV) Department at Mayo Clinic, Rochester since 1995. Dr. Ammash is the CEO of Sheik Shakhbout Medical City, a joint venture between Mayo Clinic and Abu Dhabi heath authority since 2019. His past administrative leadership roles at Mayo Clinic include; Vice-Chair, for practice, of the CV Department at Mayo Clinic Rochester, and Chair of the CV Clinical Practice Committee for Rochester and Mayo Clinic enterprise (2014-2018), co-director of the Echocardiography laboratory (2011-2014), chair of Echocardiography Clinical Practice Committee (2011-2014), director of Echocardiography training program (2008-2011). Dr Ammash also served as a member of the Midwest Specialty Care CPC Space and Remodeling Subcommittee (2016-2018). Dr. Ammash is Board Certified in Cardiovascular Diseases, with subspecialty certification in Adult Congenital Heart Disease and Echocardiography. Dr. Ammash has a Silver Level Certification from the Quality acaddemy. He attended the American University of Beirut- Lebanon and moved to the United States in 1987. Dr Ammash served on the American Board of Internal Medicine testing writing committee for the Adult Congenital Heart Disease board certification examination until 2019. He currently serves as a member of the ABIM Cardiovascular test approval committee. His resume includes more than 150 peer-reviewed published articles and 20 chapter books in addition to being an invited speaker to numerous national and international continuous medical education meetings including many in the middle east and gulf regions. He is currently the co-director for annual Echo on Marco island and Cardiovascular review course in Bahrain.

Dr. Asma Al Halaseh is a distinguished and accomplished healthcare leader with a remarkable career spanning both medicine and leadership. She earned her MBBS degree with honors from Dubai Medical College in 2002. Dr. Asma Al Halaseh currently holds the esteemed position of Chief Executive Officer at Ambulatory Healthcare Services, where she oversees the largest network of healthcare centres in the UAE. Her exceptional leadership and dedication to healthcare excellence have propelled her to this role. With over 20 years of experience in healthcare management with various established organizations such as Al Zahra Private Hospital, Gulf Marketing Group, Medcare Hospitals & Medical Centres, she has demonstrated unwavering commitment to advancing healthcare standards and services. Her strategic acumen and operational expertise have been instrumental in expanding access to quality healthcare for UAE. With a wealth of experience and a proven track record, Dr. Asma Al Halaseh stands as a beacon of excellence and innovation in the healthcare industry in the UAE

Habiba alsafar is an Emirati research scholar who has a wealth of professional and educational experience. She obtained her Bachelor of Science (BSc) in biochemistry at San Diego State University, United States of America and later her Master of Science (MSc) in Medical Engineering at the University of Liverpool in the United Kingdom. She subsequently obtained her Doctor of Philosophy (PhD) in Medical and Forensic Science at the University of Western Australia in Australia. She has since completed a one-year Global Clinical Scholars Research Training program at Harvard Medical School. Her research interest is constructing the genomic structures of individuals of Arab descent to identify genomic segments that carry gene(s) that predispose to disease. Specifically, addressing diseases that are increasing in prevalence amongst the local communities of the UAE. Dr. Alsafar has identified a gene strongly associated with the prevalence of Type 2 diabetes among the Emirati population. This is the first Genome Wide Association Study of the UAE Bedouin population and first of its kind in the Middle East. Her passion for genome has led to the description of the first whole genome sequence of Emirati subjects, insights into the genetic diversity of the population of the UAE and most recently, the description of a reference genome for the UAE population.

Alex Aliper, PhD, is the President of Insilico Medicine. He pioneered the application of AI in multi-omics data for drug discovery and drug repurposing, generative chemistry, and generative biology and put an AI-designed drug into human clinical trials. Alex built a team of over 100 AI engineers who developed state-of-the-art software products for target discovery, small molecule generation, and clinical trial outcome prediction.

Edward J. Cupler, MD, FAAN is currently the Executive Director of the Research Centre (RC) / Research and Innovation (R&I) and Consultant, Neurologist and Neuromuscular Diseases Specialist at King Faisal Specialist Hospital and Research Center (KFSH&RC), Kingdom of Saudi Arabia (KSA). He is also an Adjunct Professor in the College of Medicine, AlFaisal University and the founder of SANEM: Saudi Arabian Neuromuscular and Electrodiagnostic Medicine branch of the Saudi Neurology Society (SNS). Dr. Cupler earned his undergraduate studies and medical school at The Ohio State University in Columbus, Ohio, United States of America (USA). He completed his Internal Medicine internship at the Loyola University in Chicago and Neurology Residency at the Baylor College of Medicine in Houston followed by a Neuromuscular Diseases Fellowship at the National Institutes of Health in Bethesda. Dr. Cupler initially joined KFSH&RC Riyadh from 1996 to 2005, where he was actively involved in clinical research, post-graduate education and basic research. He then moved to Oregon Health Sciences University where he was the Director of the Neuromuscular Diseases Center, Director of the MDA Clinic and Co-Director of the ALS Center of Oregon and held the Associate Professor of Neurology position. He re-joined KFSH&RC Jeddah in 2010 as a Consultant and was later appointed Deputy Executive Director, RC. In 2021, he was assigned and relocated to the RC / R&I and was then appointed Executive Director in 2022. Dr. Cupler has authored numerous academic publications, book chapters, web-based educational activities and abstracts and has delivered lectures at local and international conferences globally. He has also mentored young neurologists and has conducted research throughout his career.

Seasoned healthcare leader with over 16 years’ experience in business operations, currently serving as Group Chief of critical infrastructure and response at Purehealth, the UAE’s largest healthcare network. Strong track record in executing successful plans in biosecurity, emergency preparedness, business resilience, radiological and nuclear emergency, managing organizational response to major disasters and pandemic and leading multi-dimensional campaigns, operational functions and large teams to ensure a consistent and cohesive approach to wide scale organizational and departmental operations. Throughout his career, he strives to continually elevate knowledge within the medical field, utilize scientific advancement and technologies to improve quality and operational efficiency. He continues to lead the UAE Biosecurity Scientific Advisory Committee, and have also served as a UAE Army Officer in the Armed Forces.

Passion, creativity, innovation and leadership are some of the words that define Dr Siddiqui and lend him the unique ability which distinguishes him from many others in the business. During his illustrious career spanning over four decades, he has successfully driven many high-profile projects and bagged various awards and accolades for his pioneering work in the healthcare domain. Starting his career as a management trainee, today he heads Arabian Healthcare Group, one of the leading healthcare groups of UAE, besides being Executive Director of the premium RAK Hospital. From choreographing the launch of Apollo Hospitals in India to establishing Belhoul Speciality Hospital and RAK Hospital in UAE and turning them into profitable ventures within a quick span, he has been instrumental in setting up several other multi-specialty hospitals with international collaborations, diagnostic laboratories, and also a medical college. His forte lies in promoting countries and institutions as medical tourism destinations and he has done commendable work within this domain by promoting UAE and bolstering RAK Hospital as the place of choice for medical tourists. In every organization that he has worked for, he has introduced fresh insight and ideas that not only position the business as a force to reckon with, but ensure that it continues to conquer more frontiers. Current positions: ● Board Member – RAK Medical and Health Sciences University, RAK Hospital and Arabian Healthcare Group ● Advisory Board Member – CEO Club International and Arab Health 2020 ● First Indian Board Member – RAK Chamber of Commerce and Industry ● Founding Board Member – UN Office for Disaster Risk Reduction Recent Awards: ● FORBES TOP 50 Healthcare Leaders 2022 ● TOP 30 Most successful self-made men –PRODIGY GLOBAL NETWORK 2022 ● The Business Leader Of The Year - The Economic Times & The World HRD Congress 2021 ● Healthcare Personality of the Year - World Medical Council 2021 ● CEO of the Year - Golden Globe Tiger Awards 2021 ● International Business Achiever – CEO Forum Mumbai 2020 ● CEO of the Year – Global Healthcare & Medical Tourism Conclave - 2019 ● FORBES Top 30 Indian Executives in the Arab World 2018 – Rank 26 - 2019 ● World Medical Council Excellence Award – Hall of Fame – 2019 ● Most Influential CEO of the Year Award 2018 – CEO Clubs Network ● FORBES Top 50 Indian Executives in the Arab World 2018 – Rank 30 ● Token of Appreciation by HH Sheikh Saud Bin Saqr Al Qasimi the Ruler of RAK and Member of Supreme Council for serving as The Member of The Board of Directors in the RAK Chamber of Commerce since 2013 onwards – 2018 ● Healthcare CEO of the Year – CEO Club International – 2017 ● Healthcare Excellence CEO of the year – India UAE Business Forum – 2017 ● Excellence in Healthcare – UAE India Economic Forum – 2017 ● Healthcare Business Mentor of the Year – Six Sigma Healthcare Award, Delhi India – 2017 ● Asia Health Award (2017) ● The Middle East HealthCare Leadership Award (2017)

Dr. Walid Zaher brings a profound wealth of experience and expertise to the forefront of CareXso, a journey that seamlessly interweaves clinical excellence, advanced education, and groundbreaking research leadership. Dr. Walid Zaher's vision for CareXso transcends geographical borders, envisioning the Middle East and Africa (MEA) as integral players in the global clinical research network. His resolute commitment to fostering diversity and inclusivity within the healthcare industry and his tireless pursuit of health innovation exemplify his transformative leadership. As he continues to shape the healthcare landscape, Dr. Zaher stands as a beacon of progress and a driving force in the quest for a healthier, more equitable world. In the United Arab Emirates (UAE), Dr. Zaher emerged as a transformative figure, directing pioneering research initiatives at SEHA and subsequently serving as Chief Research Officer at G42 Healthcare and CEO at IROS. Amid the unprecedented challenges posed by the COVID-19 pandemic, he demonstrated unwavering resilience by establishing the UAE's inaugural Contract Research Organization, building upon the resounding success of the 4Humanity Clinical Trial. Before his UAE sojourn, Dr. Zaher held prestigious positions, including Director of the College of Medicine Research Centers and an assistant professorship in regenerative medicine and stem cells at King Saud University in Riyadh. His expertise extended to consulting on the Saudi 2020 National Biotechnology and Infectious Disease plan at KASCT. Fuelled by an unrelenting desire to expand the horizons of medical knowledge, Dr. Zaher embarked on an academic odyssey, earning a Bachelor of Medicine and Surgery in Saudi Arabia. His yearning for innovation led him to pursue further education, culminating in a Master's in Medical Education, Anatomy and Embryology, and Bioscience Technology. This foundation enabled him to transcend conventional boundaries, culminating in a Ph.D. in Regenerative Medicine from Denmark. His quest for excellence also led him to Harvard-MGH, Boston, where he acquired specialized training in laser-medicine application.

Dr Ram is a Cardiothoracic Surgeon who did his training in Cardiac Surgery at the University Hospital of Wales, Cardiff, UK & Toronto General Hospital, University of Toronto, Canada. He did his Management Training at the Indian Institute of Management, Ahmedabad & Singapore Management University. He has also been associated with the Indian Institute of Healthcare Management & Research University, Jaipur, India as Vice Chairman of The Academic Advisory Council & Visiting Faculty Member. After a stint of almost 8 years abroad, he returned to India in 1999 as the CEO & Medical Director of a 110 bed Heart Institute in Western India. Subsequently he joined the Reliance Group in September 2006 to lead the team in setting up the 875 bed, quaternary care, Kokilaben Hospital in Mumbai. He was the Executive Director for more than 14 years, being involved in design, planning, project management, commissioning, operations, clinical governance & strategic planning. He was the Chief Operating Officer at the Emirates Hospitals Group, Dubai, from July 2019 till June 2023. This entailed managing 2 Hospitals, 2 Day Surgery Centres, 12 Medical Centres, 2 Rehab Centres and 5 Pharmacies across Dubai, Abu Dhabi and RAK. He has been with PureHealth as the Chief Medical Officer at The Medical Office since July 2023.

Dr. Ismail is a UK Board-Certified General and Oncoplastic Breast Surgeon with experience of more than 10 years. Dr. Ismail had received his basic medical degree from Baghdad University in Iraq. He then pursued his surgical training in the UK, completed his academic degrees, MRCS and FRCS training, then obtained his CCT in General and Oncoplastic Breast Surgery. He had training in France and Germany on the latest techniques of therapeutic Mammoplasty and Breast fat transfer. Dr. Ismail is a passionate advocate for the significance of cancer prevention and the necessity of early screenings, promoting a longer and healthier life.

Alia Abdel-Razeq, the Chief Operating Officer at CellSave Arabia, stands as a prominent figurehead in the forefront of the stem cell and regenerative medicine revolution in the Middle East. She has a background rooted in chemical and pharmaceutical engineering, complemented by extensive experience in healthcare management and research. Under Alia’s insightful leadership, CellSave Arabia has expanded its offerings to cater comprehensively to the diverse needs of individuals and institutions. Notably, a groundbreaking addition is newborn stem cell storage for longevity purposes, empowering families with future-use options with stem cells and stem cell-derived exosomes. Furthermore, CellSave Arabia is pioneering stem cell therapy services, revolutionizing treatments for conditions such as autoimmune disorders, heart disease, neurological ailments, regenerative medicine, and more.

Arindam is a business leader with 3 decades of experience in a variety of leadership roles, managing diverse organizations and their P&Ls across industry segments, working through sales, marketing, operations & process reengineering. He has donned multiple C-suite roles and served on company boards, & along the way, built strong teams and organizations for posterity, while developing a strong professional network. Arindam is Purelab’s first CEO and was involved in the formation of the entity & setting up its management structure. He led the integration of legacy lab business of Purehealth in northern emirates with acquired lab asset in Abu Dhabi, and adding new business segments over past 2 years, to create the largest lab network in the region. Business model comprises managing labs in multispeciality hospitals, clinics, and primary healthcare centres, and handling large scale national healthcare screening programs. Purelab is a 1300+ employee strong organisation with 160+ lab services performing location across 7 Emirates and is credited with running labs at prestigious SEHA hospitals and AHS Clinics in Abu Dhabi, Shaikh Khalifa Hospitals and EHS Hospitals (MOHAP) in the Northern Emirates, amongst many others. In past Arindam has held positions of CEO at SRL Diagnostics (Now Agilus) and Thyrocare, 2 of the national lab chains in India.

Dmitry Kaminskiy is an innovative entrepreneur, investor, author and philanthropist dedicated to impact investment and ethical business, with a focus on engineering the accelerated trajectory of progressive technological development for the benefit of humanity. Dmitry is a co-founder and managing partner of Deep Knowledge Group - a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, Precision Medicine, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, policy, and philanthropy. He leads the activities of the consortium’s investment arms - Deep Knowledge Ventures, focused on DeepTech and advanced science projects, and Longevity. Capital, which prioritizes the convergence of Longevity and Artificial Intelligence. In addition to his business experience, Dmitry is involved in several scientific endeavours. He has a major interest in anti-aging and healthy longevity, which is reflected in the full scope of his personal and professional activities. Dmitry is the author of the books ‘Biomarkers of Human Longevity’ and ‘Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History’.

Dr. Yasir Khan is a physician with passion and expertise in health informatics. His informatics career spans over 20 years, serving in 4 countries He completed his post-graduate training in pediatrics with the University Hospitals of Leicester and joined the National Program of Health IT for NHS where he supported standardization of clinical documentation and CPOE. For the past 12 years, he has been based in the Middle East in leadership roles for medium to large healthcare systems. He has been an advisor to public health bodies around the region focusing on E-health national strategy and its delivery. He currently functions as Director, Physician Executive for Oracle Health in the Middle East and Asia Pacific, where he champions “informatics-driven clinical excellence”. His diverse background of clinical training, and software engineering along with a master's in health policy and economics enabled him to develop various award-winning programs for better patient outcomes through information system (IS) transformations.

Eran Segal is a Professor at the Department of Computer Science and Applied Mathematics at the Weizmann Institute of Science, and adjunct Professor at Mohamed Bin Zayed University of Artificial Intelligence, heading a lab with a multi-disciplinary team of computational biologists and experimental scientists in the area of Computational and Systems biology. His group has extensive experience in AI, machine learning, computational biology, and analysis of heterogeneous high-throughput genomic data. His research focuses on Microbiome, Nutrition, Genetics, and their effect on health and disease. His aim is to develop personalized medicine based on data from large-scale and deeply phenotyped human cohorts. Prof. Segal published over 200 publications that were cited over 60,000 times, and received several awards and honors for his work, including the Overton prize, awarded annually by the International Society for Bioinformatics (ICSB) to one scientist for outstanding accomplishments in computational biology, and the Michael Bruno award. He was also elected as an EMBO member and as a member of the young Israeli academy of science. During the COVID-19 pandemic, Prof. Segal developed models for analyzing the dynamics of the pandemic and served as a senior advisor to the government of Israel. Before joining the Weizmann Institute, Prof. Segal held an independent research position at Rockefeller University, New York.

Sadia Khuram is the Chief Strategy Officer of the Pure Health Group. Sadia is responsible for the development and implementation of Pure Health’s corporate strategy, business development, and partnerships. As the Chief Strategy Officer, Sadia also drives the Research & Innovation and Products vertical for the Group. Before joining Pure Health, Sadia has worked extensively in senior management and board positions in the telecom, mobility and energy sectors. Sadia is passionate about helping businesses and organizations, especially in the healthcare sector, leverage the opportunities presented by technology to create, capture and deliver value for the patients & society in a digital economy. She actively engages with the academic and start up communities to get inspired and to support in building the next generation of disruptors, innovators and leaders. Sadia Khuram is a Sloan Fellow and has an MBA in Innovation and Global Leadership from the MIT Sloan School of Management. She has won numerous awards and accolades in her academic and professional career.

Isaac “Yitz” Applbaum is Chairman of Emkan Capital a Saudi-based Venture Capital Group. He is also a founder and General Partner at MizMaa Ventures, a $250M venture fund that invests in Israeli startup companies in the Mobility, Fintech, Cyber Security, Cloud, and Digital Healthcare space. Issac is a senior advisor to EIGHT VC Partners a $6.5BN Venture Fund which invests in Enterprise Software and Healthcare Technologies and 7Wire Ventures a Digital Healthcare Venture Group. Isaac sits on the board of directors of Anagog Technologies, Coronet, Lynx MD and is Chairman of Novo-Genomics the first Genome testing start-up in the Kingdom. He is a Senior Advisor to HE Abdullah Alswaha, The Minister of Communications and Information Technology for the Kingdom of Saudi Arabia. Isaac is also the Co-Founder of Secure Senior Connections a Social Determinant of Health platform that helps to solve loneliness in the elderly community and is the President of Health Connect Acquisitions Corporation (SNRHU), a publicly traded company in the Digital Health arena. Isaac sits on the Global Board of Directors for the Asia Society and is a Trustee of the Smithsonian’s Hirshhorn Museum and Sculpture Garden and sits on the Governance and Nominating Committees.

With over 20 years of progressive experience in the healthcare technologies and healthcare projects industry, Samer is a result-oriented entrepreneur and senior business management executive with a passion for health tech and innovation. He hold a BSc in Medical Technology, an MBA, and a Master of Applied Business Research, and have developed competencies in new business development, key account management, analytical skills, strategic management, finance, marketing, sales, and operation management. As the Co-Founder and CEO of DarDoc, Samer is determined to enhance home healthcare with innovative software solutions that can make primary healthcare services easily accessible at any time and anywhere. He carries on with the mission of building futuristic software solutions that can improve the quality, efficiency, and affordability of home healthcare. Samer has also successfully grown and led FourMed, a leading provider of effective solutions for hospitals' surgical workplaces, for over 12 years, winning multiple large OT projects in the UAE and increasing the company's profitability and value.

Yasir Khalid is the CEO and Founder of StrikeReady, an AI-driven cybersecurity firm that aims to revolutionize proactive and collaborative defense for organizations of all sizes. Before founding StrikeReady in 2019, Khalid led the Zero Day Detection initiative at FireEye, playing a key role in developing the company's second-generation threat detection products. With 15 years of experience in the cybersecurity industry and 17 patents to his name, Khalid's expertise is palpable. His latest innovation is CARA, an AI-powered Digital Assistant that drives StrikeReady's Autonomous Security Operations platform, the world's first of its kind."

Rizwan Tufail is the Group Chief Data Officer at PureHealth. He leads the group-wide data and analytics strategy and execution at Pure Health, helping the group leverage data to advance its longevity vision. He brings 30+ years of experience - across North America, Europe, Africa, and the Middle East - including 10 years leading Microsoft's work across Africa and 4+ years starting, incubating, growing and eventually selling his own startup in the Silicon Valley. He holds master's degrees in management from Harvard and Chicago Booth and is also a PhD/ABD in economics from the University of Chicago.

Christoph brings over 20 years of management experience to his position as CEO of TLEX® Institute. In his capacity, he has introduced TLEX® in more than 60 countries. The rich experience of the diverse cultures of the world and understanding of global social-economic and political scenarios has helped him to establish several public-private partnerships for social development. He is also the Managing Director of the World Forum for Ethics in Business, which has held a yearly conference in the European Parliament since 2006. He has conducted leadership, well-being, resilience, and ethics programs in Europe, the Middle East, Africa, and the Americas. Over the last 15 years, Christoph has taught in companies such as Supercell, SinnerSchrader, Accenture, Boston Consulting Group, European Chemicals Agency, Beiersdorf, GE Healthcare, Daimler, Shell, BearingPoint, American Express, the World Bank Group, the U.S. State Department, and Harvard Business School. Christoph holds a Master’s in Public Policy from the Humboldt-Viadrina School for Governance in Berlin, Germany, and has graduated with honors from the Business School Basel, Switzerland. Christoph is a certified Leadership trainer of the World Bank Group program ‘Greater than Leadership’ and a certified Integral Associate Coach through Integral Coaching, Canada.

Noor Stars, an Iraqi-American entrepreneur, just 26. Noor hosts the trendy, relatable, and booming Stars Podcast show. As a pioneering YouTuber, she was the first in the region to hit 10 million subscribers, making her a key influencer. Despite her youth, she's a successful self-made, earning titles like 'Arab Woman of the Year' and 'Beauty Influencer of the Year'. Beyond content creation, she's the face of well-known brands like Mac, L'Oréal, Benefit, Aldo, and more, showcasing her immense value and strong partnerships.

Zenia Makki bio - Zeina Makki is a highly accomplished Lebanese actress, celebrated for her versatility and captivating performances. Born and raised in Kuwait, Zeina embarked on a remarkable journey that led her to become a prominent figure in the Lebanese entertainment industry. Her passion for the arts and her unwavering determination to pursue her dreams have defined her career. Zeina Makki's artistic journey began in 2008 when she relocated to Lebanon to pursue her higher education. She enrolled in the esteemed Communication Arts program, specializing in scriptwriting and directing. Her studies provided her with a solid foundation in the technical aspects of filmmaking and storytelling, setting the stage for her future success. In 2011, Zeina achieved critical acclaim and international recognition for her documentary "Bent not Broken," which chronicled her personal journey with Scoliosis. The thought-provoking film earned her the prestigious Best Short Documentary award at the renowned Monaco Film Festival. Through her work, Zeina not only showcased her talent as a filmmaker but also demonstrated her courage and resilience in the face of adversity. Beyond her acting prowess, Zeina Makki is known for her unwavering dedication to her craft and her commitment to raising awareness about important social issues. She utilizes her platform to shed light on topics close to her heart, seeking to inspire and empower others through her work.

Ameni started modeling at the age of 18 with the ambition to become the voice of all plus-size women in the Middle East. She is a body positivity advocate and is 'The First Curvy Model of the Middle East and North Africa.' As an Arab plus-size model, Ameni constantly tries to break barriers in the region and hopes to represent all Arab women to the best of her ability. She dreams of a more inclusive and accepting society in a part of the world where body positivity is only recently being discussed. Known for her strong personality and hard-word, she hopes to influence the fashion industry in the region. She is the first Arab plus size model to walk in Paris Fashion week several times from Weinsanto to Georges Hobeika. Ameni constantly pushes brands to explore new horizons and promotes diversity and inclusivity. Ameni has worked with some of the most influential brands to share her powerful message worldwide. From being ambassador for Jean Paul Gaulthier and Dubai Fashion week/Arab Fashion council to being featured in all magazines from Vogue, Elle, Cosmopolitan, L'Officiel, Harper's Bazaar etc.. She hopes to inspire young Arab women daily and engages with them to show they can do anything they set their minds to. Ameni was French-educated and is currently completing a university degree in Fashion Design. From walking on runways to drawing dresses in the classroom, she thrives for the best and believes nothing is impossible.

Rania Hammad is an Egyptian British mother, recognized fashion influencer, and disability advocate. In 2018, Rania Hammad was 6 months pregnant when she had an accident in London that led to the loss of her leg. Despite this adversity, she continued her journey and turned this tragedy into something positive, and became a public speaker, fashion influencer, and a model representing people with disabilities.

Dr. Mohammed Naji is an Orthodontist specialized in Laser Dentistry and the Executive Director of Liberty Medical Group which was established in the UAE since 1998. He also holds a degree in Healthcare Management & Administration and achieved a milestone by leading the renowned Liberty Dental Clinic to become the first internationally accredited dental practice in the MENA region by the ISQua approved ACHS accreditation. Dr. Naji and his organization are active members of Dubai Health Experience (DXH) the prestigious brand conceived by the Dubai Health Authority (DHA) to strengthen and promote the medical tourism strategies.

After a stellar 13 year career in marketing for a multinational, Miriam faced multiple burn outs and realized that mental wellbeing was a priority for her and her family. In 2021 she founded the Middle Easts first ever wellness & beauty platform TRU & Beyond. Now TRU is not only a platform promoting wellness and beauty but it has evolved into representing global beauty and wellness artists, organizing workshops, consulting for international brands and lastly organizing pop ups in the Middle East. Most recent Wellness and Beauty pop up was held in the prestigious mountains of Lebanon with artists from around the world, offering the best services.

Dr. Cherine, a Lebanese Family Physician, is a graduate of Saint Joseph University in Beirut, as well as a Morphological and Anti-Aging Medicine specialist from the University of Paul Sabatier in Toulouse, France. With a decade of specialized experience, starting in treating cancer survivors at Clemenceau Medical Center, affiliated with John Hopkins International, she is an expert in integrative and anti-aging medicine. She is considered a leading practitioner in preventive health and longevity, dedicated to helping individuals age in good health with balance, sanity, and vitality. A prominent educator at Saint Joseph University Faculty of Medicine in the Oncology and Public Health departments. She currently serves as the medical director of the “In Good Health Clinic” in Downtown Beirut; she also serves as the wellness consultant Physician for Unilever Levant.

Dr. Samar Khalil is a general and cosmetic dermatologist practicing in Dubai and Lebanon. She obtained her Medical Doctorate from the American University of Beirut in 2016. She went on to pursue her dermatology residency training at the American University of Beirut Medical Center. Dr. Samar’s expertise encompasses treating skin diseases as well as using non- and minimally invasive procedures, such as injectables and lasers, for skin rejuvenation.

Mirna Sabbagh is a licensed dietitian, International Board Certified Lactation Consultant, Podcaster, and Health Influencer. She has created a community of more than 300,000 parents that love to learn about optimal health for their children. She has created several online courses and recipe books for parents and spreads awareness across several media outlets in the Arab region. She is very passionate about creating better foundations for children and a more supportive environment for parents.

Chiara Seidenader is the founder of Beauty Treats, the first fully functional keto and gluten-free snack filled with superfoods and collagen peptides. Her extensive background in nutrition & fitness, health & supplementation has naturally led her to educate people about the importance of a healthier living.

Vaishali embodies the title of a 'Creator of Possibilities,' with her unwavering passion for helping individuals discover their inner peace, reclaim their confidence, and purposefully shape their reality. With a rich tapestry of experience spanning over 14 years in aviation, she has consistently demonstrated exceptional leadership and coaching acumen, fashioning award-winning people development journeys. In addition, she has conducted comprehensive mindfulness and well-being sessions utilizing different modalities such as Coaching, Yoga & Meditation, Sound Immersion, and Breathwork Beyond her corporate feats, Vaishali has earned recognition from the Government of Fujairah, UAE, for her impactful contribution to the "Fujairah Meditates for Peace" initiative in 2018. She has also been recognized with the "Splash Heart of Gold" award for her outstanding humanitarian work through the Bring Home Humanitarian Foundation, conducting transformative Train-The-Trainer sessions for NGOs working with refugees in Iraq. Her overarching vision extends to leading transformative change initiatives that positively impact our future. Her dedication to societal well-being propels her to engage in a myriad of projects, including fostering a Tribal School Development Project in India, adopting a Children's Home in Nepal, and orchestrating "Breath Water Sound" workshops for blue-collar employees in the UAE.

Sally is a senior presenter and keynote speaker who has interviewed many of the world’s most influential change-makers across every field over the last two decades. She regularly speaks on transformation, leadership, communication, women's empowerment, and intercultural dialogue. From Prince Khaled bin Alwaleed bin Talal to Nobel Laureates like Kailash Satyarthi, Hollywood superstars like Steve Harvey, Olympic medallists like Ibtihaj Muhammad, visionaries like Dr Jane Goodall, top coaches and authors like Robin Sharma and Jay Shetty, amongst many others, Sally has a gift for telling the stories of those who have made a global impact, revealing deeper insights that others miss. As an Arab-Australian, Sally is passionate about powerful stories that explore diverse narratives and are part of conversations driving change worldwide.

Samar is an online editor, covering the latest on celebrities and the business of fashion, music and media. She has a Master's degree in Journalism from The University of Melbourne.

Jamila is a senior reporter at Forbes Middle East, where she leads the content strategy vertical across the English and Arabic editorial teams. From the world's wealthiest individuals to the sustainability champions and economic meltdowns in between, Jamila covers industry-wide regional and global issues.

Dareen Barbar, Lebanese born on 19th January 1978. A Motivational Speaker, Life Coach and an aspiring Athlete. Dareen stepped onto the World stage after making history in the most glamorous events on the planet, the World, Beauty, Fitness and Fashion Show in London 2017, where she competed in the Transformation and Makeover Division and won. She became the first Arab Amputee to participate in such a pageant. She is an ambassador of inclusion for people of determination aka the disabled in the UAE. Lost her leg to cancer at the age of 15, which turned her life around. But that didn’t stop her from living her life to the full and overcoming the hardships. Her passion for sports was revived after her broken hip in 2013 that lead her to adopt a healthy life style of exercising and eating healthy and earned her fitness instructor and nutritionist qualification. She got awarded and honored in several events, for her achievements (DIAFA, Mena creators awards, IFBB, and was featured in many magazines, such as Vogue Arabia, Daily mail, Marie Claire. The first Arab amputee to complete a super sprint in Dubai women’s triathlon 2018. Dareen’s name entered history in June 2021 with her recent big achievement of breaking the Guinness World Record for the longest Samson’s chair sit, also known as a static wall sit, by a female contender. Dareen won the title after completing the sit for two minutes and 8.24 seconds, and the record also makes her the first female amputee to hold a Guinness World Record in the Middle East. Her journey has impacted and still impacting a lot of people from all over the world. Dareen is a brand ambassador for big nanes like adidas and Victoria’s Secret. Her latest achievements is her song BASMA بصمة. Dareen is a wife and a mother to two amazing kids. Her message is “disability is an extra-ordinary ability that makes the impossible possible”

Ramia is a Senior Producer and Presenter at Forbes Middle East, as well as a Moderator with a long history of hosting a variety of public and private sector events. At Forbes, Ramia hosts the Daily Brief, an online twice daily show focusing on breaking business news. She also conducts interviews with international business and world leaders. From its launch in 2007 until 2021, Ramia led the Emirates News broadcast on Dubai One TV as the Presenter and News Bulletin Editor. Previous to her role at Emirates News, from 2002 to 2007, Ramia presented and produced the program Business Arabia, which aired internationally on CNBC. Ramia has interviewed several world leaders including General Pervez Musharraf, President of Pakistan, Mohammed Khatami, President of Iran, Gerhard Schroeder, Chancellor of Germany and Jimmy Carter, US President. She is a moderator at major events including the World Government Summit in Dubai, the Middle East Investment Forum, and the Forbes 30/50 Summit, to name a few. Ramia holds a MA in Global Diplomacy-International Relations from the University of London, SOAS, as well as a BA in Communications from the University of Winnipeg and an associate degree in Journalism from Red River College.